Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 21, 2022 - Issue 8
Submit an article Journal homepage
2,797
Views
1
CrossRef citations to date
0
Altmetric
Editorial

Venous thromboembolism risk with Janus kinase inhibitors: Is it a class wide effect?

Ameen Jubbera University Hospitals of Leicester NHS Trust, Infirmary Square, Leicester, UKCorrespondence[email protected]
View further author information
,
Jonathan Woodwardb Royal Free London NHS Foundation Trust, London, UKView further author information
,
Hasan Tahirc Division of Medicine, University College London, London, UKORCID Iconhttps://orcid.org/0000-0002-2148-736XView further author information
ORCID Icon &
Arumugam Moorthyd College of Life Sciences, University of Leicester, Leicester, UKView further author information
Pages 1005-1007 | Received 02 Mar 2022, Accepted 07 Jul 2022, Published online: 13 Jul 2022

Figures & data

This paper does not have figures.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.